{"id":"https://openalex.org/W7207526201","doi":"https://doi.org/10.31083/pharmazie52238","title":"Nanotechnology-Based Strategies for Treating Skin Hyperpigmentation: A Review of Current Advances and Challenges","display_name":"Nanotechnology-Based Strategies for Treating Skin Hyperpigmentation: A Review of Current Advances and Challenges","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-20","ids":{"openalex":"https://openalex.org/W7207526201","doi":"https://doi.org/10.31083/pharmazie52238","pmid":"https://pubmed.ncbi.nlm.nih.gov/42695243"},"language":"en","primary_location":{"id":"doi:10.31083/pharmazie52238","doi":"https://doi.org/10.31083/pharmazie52238","is_oa":true,"landing_page_url":"https://doi.org/10.31083/pharmazie52238","pdf_url":"https://storage.imrpress.com/IMR/2090355342740086800/application/3053-691X-81-8-52238.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7207526201"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://storage.imrpress.com/IMR/2090355342740086800/application/3053-691X-81-8-52238.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5149531148","display_name":"Gabriela F\u00e1tima de Lima Flores","orcid":"https://orcid.org/0000-0002-8245-2558","observed_orcids":["https://orcid.org/0000-0002-8245-2558"]},"institutions":[{"id":"https://openalex.org/I130442723","display_name":"Universidade Federal do Rio Grande do Sul","ror":"https://ror.org/041yk2d64","country_code":"BR","type":"education","lineage":["https://openalex.org/I130442723"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gabriela F\u00e1tima de Lima Flores","raw_affiliation_strings":["School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-8245-2558","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil","institution_ids":["https://openalex.org/I130442723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046371453","display_name":"Gabriela Fusinatto de Oliveira","orcid":"https://orcid.org/0009-0002-1628-8574","observed_orcids":["https://orcid.org/0009-0002-1628-8574"]},"institutions":[{"id":"https://openalex.org/I130442723","display_name":"Universidade Federal do Rio Grande do Sul","ror":"https://ror.org/041yk2d64","country_code":"BR","type":"education","lineage":["https://openalex.org/I130442723"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gabriela Fusinatto de Oliveira","raw_affiliation_strings":["School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil"],"raw_orcid":"https://orcid.org/0009-0002-1628-8574","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil","institution_ids":["https://openalex.org/I130442723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5123112831","display_name":"D\u00e9bora Cristine Chrisostomo Dias","orcid":"https://orcid.org/0009-0000-1714-2062","observed_orcids":["https://orcid.org/0009-0000-1714-2062"]},"institutions":[{"id":"https://openalex.org/I126460647","display_name":"Universidade Federal do Rio Grande","ror":"https://ror.org/05hpfkn88","country_code":"BR","type":"education","lineage":["https://openalex.org/I126460647"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Debora Cristine Chrisostomo Dias","raw_affiliation_strings":["School of Medicine, Federal University of Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil"],"raw_orcid":"https://orcid.org/0009-0000-1714-2062","affiliations":[{"raw_affiliation_string":"School of Medicine, Federal University of Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil","institution_ids":["https://openalex.org/I126460647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048720050","display_name":"Ana Paula Horn","orcid":"https://orcid.org/0000-0002-6854-8545","observed_orcids":["https://orcid.org/0000-0002-6854-8545"]},"institutions":[{"id":"https://openalex.org/I126460647","display_name":"Universidade Federal do Rio Grande","ror":"https://ror.org/05hpfkn88","country_code":"BR","type":"education","lineage":["https://openalex.org/I126460647"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Paula Horn","raw_affiliation_strings":["Institute of Biological Sciences, Federal University of Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-6854-8545","affiliations":[{"raw_affiliation_string":"Institute of Biological Sciences, Federal University of Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil","institution_ids":["https://openalex.org/I126460647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019017893","display_name":"Cristiana Lima Dora","orcid":"https://orcid.org/0000-0002-9198-437X","observed_orcids":["https://orcid.org/0000-0002-9198-437X"]},"institutions":[{"id":"https://openalex.org/I126460647","display_name":"Universidade Federal do Rio Grande","ror":"https://ror.org/05hpfkn88","country_code":"BR","type":"education","lineage":["https://openalex.org/I126460647"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Cristiana Lima Dora","raw_affiliation_strings":["School of Medicine, Federal University of Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-9198-437X","affiliations":[{"raw_affiliation_string":"School of Medicine, Federal University of Rio Grande (FURG), Rio Grande, RS 96203-900, Brazil","institution_ids":["https://openalex.org/I126460647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041503611","display_name":"L. Koester","orcid":"https://orcid.org/0000-0002-1043-5855","observed_orcids":["https://orcid.org/0000-0002-1043-5855","https://orcid.org/0000-0002-4913-3475"]},"institutions":[{"id":"https://openalex.org/I130442723","display_name":"Universidade Federal do Rio Grande do Sul","ror":"https://ror.org/041yk2d64","country_code":"BR","type":"education","lineage":["https://openalex.org/I130442723"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Let\u00edcia Scherer Koester","raw_affiliation_strings":["School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-1043-5855","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil","institution_ids":["https://openalex.org/I130442723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069131356","display_name":"Fl\u00e1via Nathiely Silveira Fachel","orcid":"https://orcid.org/0000-0002-0777-9497","observed_orcids":["https://orcid.org/0000-0002-0777-9497"]},"institutions":[{"id":"https://openalex.org/I130442723","display_name":"Universidade Federal do Rio Grande do Sul","ror":"https://ror.org/041yk2d64","country_code":"BR","type":"education","lineage":["https://openalex.org/I130442723"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fl\u00e1via Nathiely Silveira Fachel","raw_affiliation_strings":["School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-0777-9497","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil","institution_ids":["https://openalex.org/I130442723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063389304","display_name":"H\u00e9lder Ferreira Teixeira","orcid":"https://orcid.org/0000-0002-5808-3043","observed_orcids":["https://orcid.org/0000-0002-5808-3043"]},"institutions":[{"id":"https://openalex.org/I130442723","display_name":"Universidade Federal do Rio Grande do Sul","ror":"https://ror.org/041yk2d64","country_code":"BR","type":"education","lineage":["https://openalex.org/I130442723"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Helder Ferreira Teixeira","raw_affiliation_strings":["School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-5808-3043","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS 90610-000, Brazil","institution_ids":["https://openalex.org/I130442723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5063389304"],"corresponding_institution_ids":["https://openalex.org/I130442723"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"8","first_page":"52238","last_page":"52238"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperpigmentation","display_name":"hyperpigmentation","score":1.0},{"id":"https://openalex.org/keywords/nanotechnology-based-drug-delivery","display_name":"nanotechnology-based drug delivery","score":0.875},{"id":"https://openalex.org/keywords/depigmenting-agents","display_name":"depigmenting agents","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tyrosinase-inhibition","display_name":"tyrosinase inhibition","score":0.871999979019165},{"id":"https://openalex.org/keywords/lipid-based-nanosystems","display_name":"lipid-based nanosystems","score":0.8730000257492065},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nanoemulsions","display_name":"nanoemulsions","score":1.0},{"id":"https://openalex.org/keywords/solid-lipid-nanoparticles","display_name":"solid lipid nanoparticles","score":1.0},{"id":"https://openalex.org/keywords/nanostructured-lipid-carriers","display_name":"nanostructured lipid carriers","score":1.0},{"id":"https://openalex.org/keywords/topical-preparations","display_name":"topical formulation","score":0.6050000190734863},{"id":"https://openalex.org/keywords/skin-permeation","display_name":"skin permeation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/controlled-release","display_name":"controlled release","score":0.7599999904632568},{"id":"https://openalex.org/keywords/melasma","display_name":"melasma","score":0.7170000076293945},{"id":"https://openalex.org/keywords/post-inflammatory-hyperpigmentation","display_name":"post-inflammatory hyperpigmentation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/solar-lentigo","display_name":"solar lentigo","score":0.7910000085830688},{"id":"https://openalex.org/keywords/drug-induced-hyperpigmentation","display_name":"drug-induced hyperpigmentation","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6802999973297119},{"id":"https://openalex.org/C3019129585","wikidata":"https://www.wikidata.org/wiki/Q77776","display_name":"Skin irritation","level":2,"score":0.6173999905586243},{"id":"https://openalex.org/C2776728111","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Hyperpigmentation","level":2,"score":0.5924999713897705},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5597000122070312},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5148000121116638},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4074000120162964},{"id":"https://openalex.org/C2983812674","wikidata":"https://www.wikidata.org/wiki/Q134808","display_name":"Delivery system","level":2,"score":0.40230000019073486},{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.4009000062942505},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.39809998869895935},{"id":"https://openalex.org/C107538193","wikidata":"https://www.wikidata.org/wiki/Q187526","display_name":"Melanin","level":2,"score":0.38850000500679016},{"id":"https://openalex.org/C2779717098","wikidata":"https://www.wikidata.org/wiki/Q131207","display_name":"Cosmetics","level":2,"score":0.3630000054836273},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.34880000352859497},{"id":"https://openalex.org/C2777063393","wikidata":"https://www.wikidata.org/wiki/Q77776","display_name":"Irritation","level":2,"score":0.3422999978065491},{"id":"https://openalex.org/C87554066","wikidata":"https://www.wikidata.org/wiki/Q85942926","display_name":"Tyrosinase","level":3,"score":0.3165999948978424},{"id":"https://openalex.org/C163588942","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Controlled release","level":2,"score":0.314300000667572},{"id":"https://openalex.org/C2777035695","wikidata":"https://www.wikidata.org/wiki/Q1929023","display_name":"Dry skin","level":2,"score":0.29190000891685486},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.28999999165534973},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.2791999876499176},{"id":"https://openalex.org/C1318750","wikidata":"https://www.wikidata.org/wiki/Q865663","display_name":"Biocompatible material","level":2,"score":0.27399998903274536},{"id":"https://openalex.org/C2909381827","wikidata":"https://www.wikidata.org/wiki/Q1641068","display_name":"Skin hyperpigmentation","level":3,"score":0.27390000224113464},{"id":"https://openalex.org/C2779078452","wikidata":"https://www.wikidata.org/wiki/Q1416124","display_name":"Skin whitening","level":3,"score":0.2680000066757202},{"id":"https://openalex.org/C2777459323","wikidata":"https://www.wikidata.org/wiki/Q5259911","display_name":"Human skin","level":2,"score":0.2667999863624573}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012869","descriptor_name":"Skin Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017495","descriptor_name":"Hyperpigmentation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D036103","descriptor_name":"Nanotechnology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062327","descriptor_name":"Skin Lightening Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.31083/pharmazie52238","doi":"https://doi.org/10.31083/pharmazie52238","is_oa":true,"landing_page_url":"https://doi.org/10.31083/pharmazie52238","pdf_url":"https://storage.imrpress.com/IMR/2090355342740086800/application/3053-691X-81-8-52238.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},{"id":"pmid:42695243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42695243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.31083/pharmazie52238","doi":"https://doi.org/10.31083/pharmazie52238","is_oa":true,"landing_page_url":"https://doi.org/10.31083/pharmazie52238","pdf_url":"https://storage.imrpress.com/IMR/2090355342740086800/application/3053-691X-81-8-52238.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1852309229","display_name":null,"funder_award_id":"420025/2021\u20139","funder_id":"https://openalex.org/F4320322025","funder_display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"},{"id":"https://openalex.org/G2703941475","display_name":null,"funder_award_id":"420025/2021-9","funder_id":"https://openalex.org/F4320321091","funder_display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior"}],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"},{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7207526201.pdf","grobid_xml":"https://content.openalex.org/works/W7207526201.grobid-xml"},"referenced_works_count":95,"referenced_works":["https://openalex.org/W33694657","https://openalex.org/W1484861203","https://openalex.org/W1517407269","https://openalex.org/W1564891630","https://openalex.org/W1759473510","https://openalex.org/W1966326996","https://openalex.org/W1990005278","https://openalex.org/W1992083471","https://openalex.org/W2000596317","https://openalex.org/W2001239820","https://openalex.org/W2015296278","https://openalex.org/W2016331364","https://openalex.org/W2016440156","https://openalex.org/W2020349703","https://openalex.org/W2042978552","https://openalex.org/W2057155063","https://openalex.org/W2061046326","https://openalex.org/W2072657606","https://openalex.org/W2100011985","https://openalex.org/W2126227905","https://openalex.org/W2183185428","https://openalex.org/W2259068583","https://openalex.org/W2406041089","https://openalex.org/W2547070871","https://openalex.org/W2556885080","https://openalex.org/W2557585037","https://openalex.org/W2575981937","https://openalex.org/W2581886868","https://openalex.org/W2621439107","https://openalex.org/W2623669081","https://openalex.org/W2750841772","https://openalex.org/W2767140725","https://openalex.org/W2782734757","https://openalex.org/W2786693416","https://openalex.org/W2789879823","https://openalex.org/W2896399282","https://openalex.org/W2897078246","https://openalex.org/W2898088982","https://openalex.org/W2910518823","https://openalex.org/W2911439446","https://openalex.org/W2946435487","https://openalex.org/W2982614477","https://openalex.org/W2987256980","https://openalex.org/W2998622989","https://openalex.org/W3006000352","https://openalex.org/W3011187945","https://openalex.org/W3014521721","https://openalex.org/W3018967305","https://openalex.org/W3026958323","https://openalex.org/W3028890341","https://openalex.org/W3037610581","https://openalex.org/W3046940940","https://openalex.org/W3047189211","https://openalex.org/W3048581459","https://openalex.org/W3090641496","https://openalex.org/W3120880071","https://openalex.org/W3121251509","https://openalex.org/W3126860972","https://openalex.org/W3137859007","https://openalex.org/W3176477567","https://openalex.org/W3193015189","https://openalex.org/W4210681211","https://openalex.org/W4210711903","https://openalex.org/W4223922238","https://openalex.org/W4225615925","https://openalex.org/W4245224585","https://openalex.org/W4250881817","https://openalex.org/W4281927581","https://openalex.org/W4285900158","https://openalex.org/W4290839371","https://openalex.org/W4293581294","https://openalex.org/W4294636790","https://openalex.org/W4297237931","https://openalex.org/W4306385981","https://openalex.org/W4313159266","https://openalex.org/W4313640750","https://openalex.org/W4318832762","https://openalex.org/W4367301633","https://openalex.org/W4367397055","https://openalex.org/W4383955267","https://openalex.org/W4385266969","https://openalex.org/W4390699880","https://openalex.org/W4391815187","https://openalex.org/W4392429668","https://openalex.org/W4393165634","https://openalex.org/W4399459223","https://openalex.org/W4400512388","https://openalex.org/W4401818076","https://openalex.org/W4401977383","https://openalex.org/W4402316253","https://openalex.org/W4402468384","https://openalex.org/W4402638102","https://openalex.org/W4404673653","https://openalex.org/W4404695770","https://openalex.org/W4413406788"],"related_works":["https://openalex.org/W7215207120","https://openalex.org/W4399872998","https://openalex.org/W4285900158","https://openalex.org/W7213275452","https://openalex.org/W4392453658","https://openalex.org/W4313245395","https://openalex.org/W3047189211","https://openalex.org/W2898088982","https://openalex.org/W4408128115","https://openalex.org/W4387603627"],"abstract_inverted_index":{"Skin":[0],"hyperpigmentation":[1],"is":[2],"a":[3,94,179],"common":[4],"dermatological":[5],"condition":[6],"characterized":[7],"by":[8],"excessive":[9],"melanin":[10],"accumulation":[11,166],"in":[12,86,170],"the":[13,74,130,141,186],"epidermis,":[14],"dermis,":[15],"or":[16],"both,":[17],"resulting":[18],"from":[19],"disorders":[20],"such":[21,57],"as":[22,58,70],"melasma,":[23],"post-inflammatory":[24],"hyperpigmentation,":[25,27,92],"drug-induced":[26],"and":[28,54,60,106,118,139,150,164,181,188],"solar":[29],"lentigo.":[30],"Conventional":[31],"treatments":[32,192],"are":[33],"mainly":[34],"based":[35],"on":[36,97],"tyrosinase":[37,159],"inhibition;":[38],"however,":[39],"many":[40],"depigmenting":[41,78,145],"agents":[42,146],"have":[43,68],"limitations,":[44],"including":[45,100],"low":[46],"stability,":[47,132],"poor":[48],"skin":[49,91,137,172,194],"permeation,":[50],"prolonged":[51],"treatment":[52],"durations,":[53],"adverse":[55,151],"effects":[56],"irritation":[59],"dermatitis.":[61],"In":[62,153],"this":[63,81],"context,":[64],"nanotechnology-based":[65,87,175],"delivery":[66,176],"systems":[67,177],"emerged":[69],"promising":[71,180],"alternatives":[72],"for":[73,89,184,193],"topical":[75,191],"administration":[76],"of":[77,112,144,167,190],"compounds.":[79],"Therefore,":[80],"review":[82],"discusses":[83],"recent":[84],"advances":[85],"strategies":[88],"treating":[90],"with":[93],"primary":[95],"focus":[96],"lipid-based":[98],"nanosystems,":[99],"liposomes,":[101],"nanoemulsions,":[102],"solid":[103],"lipid":[104,108],"nanoparticles,":[105],"nanostructured":[107],"carriers.":[109],"A":[110],"total":[111],"33":[113],"studies":[114,124,155],"published":[115],"between":[116],"2000":[117],"2025":[119],"were":[120],"analyzed.":[121],"The":[122],"reviewed":[123],"demonstrated":[125],"that":[126],"nanoencapsulation":[127],"may":[128],"improve":[129],"physicochemical":[131],"enable":[133],"controlled":[134],"release,":[135],"enhance":[136],"permeation/retention,":[138],"increase":[140],"therapeutic":[142],"performance":[143],"while":[147],"reducing":[148],"toxicity":[149],"effects.":[152],"vitro":[154],"also":[156],"reported":[157],"enhanced":[158],"inhibition,":[160],"high":[161],"cell":[162],"viability,":[163],"increased":[165],"active":[168],"compounds":[169],"different":[171],"layers.":[173],"Overall,":[174],"represent":[178],"versatile":[182],"approach":[183],"improving":[185],"efficacy":[187],"safety":[189],"hyperpigmentation.":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7207526201","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2026-09-04T00:00:00"}
